World's Best Scientists 2026 revealed!
Award Badge
Biology and Biochemistry
Canada
2023

D-Index & Metrics

Biology and Biochemistry

D-Index
79
Citations
19276
World Ranking
4385
National Ranking
149

Richard Béliveau publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Richard Béliveau sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 313 publications — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Richard Béliveau D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Richard Béliveau sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 79 D-Index — 79th percentile

79% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Research.com Recognitions

  • 2023 - Research.com Biology and Biochemistry in Canada Leader Award

Overview

Richard Béliveau is affiliated with the University of Quebec at Montreal in Canada. Their research primarily focuses on the fields of Biochemistry, Genetics, and Molecular Biology, with significant contributions to Molecular Biology, Cancer Research, Oncology, Immunology, and Radiology, Nuclear Medicine, and Imaging.

Their recent publications reflect a concentration on peptide-drug conjugates targeting cancer, particularly exploring therapeutics involving the sortilin receptor. Notable papers include:

  • TH1902, a new docetaxel-peptide conjugate for the treatment of sortilin-positive triple-negative breast cancer (2021, Cancer Science)
  • The Peptide-Drug Conjugate TH1902: A New Sortilin Receptor-Mediated Cancer Therapeutic against Ovarian and Endometrial Cancers (2022, Cancers)
  • New Peptide-Drug Conjugates for Precise Targeting of SORT1-Mediated Vasculogenic Mimicry in the Tumor Microenvironment of TNBC-Derived MDA-MB-231 Breast and Ovarian ES-2 Clear Cell Carcinoma Cells (2021, Frontiers in Oncology)
  • The TH1902 Docetaxel Peptide-Drug Conjugate Inhibits Xenografts Growth of Human SORT1-Positive Ovarian and Triple-Negative Breast Cancer Stem-like Cells (2022, Pharmaceutics)
  • Sudocetaxel Zendusortide (TH1902) triggers the cGAS/STING pathway and potentiates anti-PD-L1 immune-mediated tumor cell killing (2024, Frontiers in Immunology)

Richard Béliveau frequently publishes in venues such as:

  • Cancer Research
  • Frontiers in Immunology
  • Cancer Science
  • Cancers
  • Frontiers in Oncology

Frequent collaborators in their research include Michel Demeule, Alain Zgheib, Christian Marsolais, Borhane Annabi, and Jean-Christophe Currie. This collaboration network highlights a consistent team-based approach in cancer research and molecular therapeutics development.

The primary research topics addressed in their work cover:

  • RNA Research and Splicing
  • Cancer, Lipids, and Metabolism
  • RNA Interference and Gene Delivery
  • Interferon and Immune Responses
  • Ubiquitin and Proteasome Pathways
  • Protein Degradation and Inhibitors
  • Angiogenesis and VEGF in Cancer

These topics underscore an interrelated focus on molecular mechanisms involved in cancer biology, immune signaling pathways, and targeted therapeutic strategies. The integration of peptide-drug conjugate technology in their research suggests efforts toward precision medicine approaches in oncology.

Best Publications

  • Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector angiopep-2.

    Michel Demeule;Jean-Christophe Currie;Yanick Bertrand;Christian Ché

  • Matrix metalloproteinase inhibition by green tea catechins.

    Michel Demeule;Mathieu Brossard;Martine Pagé;Denis Gingras

  • Identification and Design of Peptides as a New Drug Delivery System for the Brain

    Michel Demeule;Anthony Régina;Christian Ché;Julie Poirier

  • Antitumour activity of ANG1005, a conjugate between paclitaxel and the new brain delivery vector Angiopep-2.

    Régina A;Demeule M;Ché C;Lavallée I

  • Inhibition of the multidrug resistance P-glycoprotein activity by green tea polyphenols.

    Julie Jodoin;Michel Demeule;Michel Demeule;Richard Béliveau;Richard Béliveau

  • Hypoxia promotes murine bone-marrow-derived stromal cell migration and tube formation.

    Borhane Annabi;Ying‐Ta Lee;Sandra Turcotte;Emmanuelle Naud

  • Regulation of vascular endothelial growth factor receptor-2 activity by caveolin-1 and plasma membrane cholesterol.

    Lyne Labrecque;Isabelle Royal;David S. Surprenant;W. Cam Patterson

  • P-glycoprotein is strongly expressed in the luminal membranes of the endothelium of blood vessels in the brain.

    Édith Beaulieu;Michel Demeule;Lucian Ghitescu;Richard Béliveau

  • Green Tea Catechins Inhibit Vascular Endothelial Growth Factor Receptor Phosphorylation

    Sylvie Lamy;Denis Gingras;Richard Béliveau

  • Drug transport to the brain: key roles for the efflux pump P-glycoprotein in the blood-brain barrier.

    Michel Demeule;Anthony Régina;Julie Jodoin;Alain Laplante

  • Inhibition of cancer cell proliferation and suppression of TNF-induced activation of NFkappaB by edible berry juice.

    Dominique Boivin;Mélanie Blanchette;Stéphane Barrette;Albert Moghrabi

  • High transcytosis of melanotransferrin (P97) across the blood-brain barrier.

    Michel Demeule;Julie Poirier;Julie Jodoin;Yanick Bertrand

  • Phosphorylation states of Cdc42 and RhoA regulate their interactions with Rho GDP dissociation inhibitor and their extraction from biological membranes.

    Marie-Annick Forget;Richard R. Desrosiers;Denis Gingras;Richard Béliveau

  • Green tea polyphenol (-)-epigallocatechin 3-gallate inhibits MMP-2 secretion and MT1-MMP-driven migration in glioblastoma cells.

    Borhane Annabi;Marie Paule Lachambre;Nathalie Bousquet-Gagnon;Martine Page

  • Curcumin inhibits tumor growth and angiogenesis in glioblastoma xenografts.

    Marie-Claude Perry;Michel Demeule;Anthony Régina;Robert Moumdjian

  • Propranolol suppresses angiogenesis in vitro: inhibition of proliferation, migration, and differentiation of endothelial cells.

    Sylvie Lamy;Marie-Paule Lachambre;Simon Lord-Dufour;Richard Béliveau

  • P-glycoprotein is localized in caveolae in resistant cells and in brain capillaries

    Michel Demeule;Michel Demeule;Julie Jodoin;Julie Jodoin;Denis Gingras;Denis Gingras;Richard Béliveau;Richard Béliveau

  • Quercetin abrogates IL-6/STAT3 signaling and inhibits glioblastoma cell line growth and migration

    Jonathan Michaud-Levesque;Nathalie Bousquet-Gagnon;Richard Béliveau

  • Expression of matrix metalloproteinases and their inhibitors in human brain tumors.

    Kachra Z;Beaulieu E;Delbecchi L;Mousseau N

  • Physiological roles of matrix metalloproteinases: implications for tumor growth and metastasis.

    Marie-Annick Forget;Richard R Desrosiers;Richard Béliveau

Frequent Co-Authors

Jacques Galipeau
Jacques Galipeau University of Wisconsin–Madison
Gillian Murphy
Gillian Murphy University of Cambridge
Yves Durocher
Yves Durocher National Academies of Sciences, Engineering, and Medicine
Danica Stanimirovic
Danica Stanimirovic National Research Council Canada
Roméo Cecchelli
Roméo Cecchelli Artois University
Robert E. Hawkins
Robert E. Hawkins University of Manchester
Pavel Hamet
Pavel Hamet University of Montreal
Philippe Sarret
Philippe Sarret Université de Sherbrooke
Christopher F. Higgins
Christopher F. Higgins Hammersmith Hospital
Daniel Bélanger
Daniel Bélanger University of Quebec at Montreal

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Richard Béliveau

Trending Scientists

Recently Published Articles